ERBB2 and breast cancer: The TCGA repository data indicated that all BC subtypes, including luminal, HER2-enriched (HER2-E), and triple-negative breast cancer (TNBC) showed increased IMMT levels, while HER2-E had higher IMMT levels than luminal (Fig. 3B).